Filsuvez (AP101) - Chiesi
FILS-EBS: Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex (clinicaltrials.gov) - Aug 11, 2026 - P2 | N=10 | Not yet recruiting | Sponsor: Stanford University 
New P2 trial
http://clinicaltrials.gov/ct2/show/NCT07756138
 
Aug 11, 2026
 
Prev Next